Opening soonN/AAges 18 Years and up
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
Sponsor: University Medical Center Groningen · NCT06726512 on ClinicalTrials.gov ↗
Conditions studied
Oral CancerOsteosarcomaSoft Tissue SarcomaOral Squamous Cell Carcinoma (OSCC)
What it tests
- XEOS AURA 10device
Where it's running1 site
1 international site
University Medical Center Groningen
Groningen, Netherlands 9713 GZ
- Jasper Vonk, Dr(contact)0631794010[email protected]
- Rik de Jong(contact)0611523057[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Age ≥18 years. * Patient is confirmed with oral squamous cell carcinoma, soft tissue sarcoma or osteosarcoma. * Patient is indicated to undergo curative surgery of the primary tumor. * Patient is estimated compliant for study participation by the investigator. * Written informed consent. Exclusion Criteria: * Medical or psychiatric conditions that compromise the patient's ability to give informed consent; * Patient has previously received radiotherapy of the primary tumor region; * Patient has participated in other clinical studies with radiation exposure of more than 1 mSv in the past 12 months; * A blood glucose level over 200 mg/dL on the day of surgery. * Pregnancy or lactation.
Updated 2024-12-10 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.